Angiotensin II receptor blocker usage and risk of major adverse cardiac events in ESRD
碩士 === 國立交通大學 === 生物資訊及系統生物研究所 === 103 === Background: End-stage renal disease (ESRD) will increase the risk of cardiovascular disease. Studies have shown that the occurrence of cardiovascular disease is directly related to renal deterioration. Angiotensin II receptor blocker (ARB) has the effect of...
| Main Authors: | , |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | zh-TW |
| Published: |
2015
|
| Online Access: | http://ndltd.ncl.edu.tw/handle/23430444846155712529 |